lunes, 28 de septiembre de 2020

CDER New: 9/28/2020



What's New Related to Drugs
September 25, 2020

Recent New and Generic Drug Approvals

This report displays final approvals and tentative approvals of original and supplemental applications for the two days beginning on the earliest date listed below. Some approvals may be added to the Drugs@FDA database after this time span. For comprehensive approval reports, please use the monthly "All Approvals" report on Drugs@FDA.

September 25, 2020

Drug Name and
Application Number
Active IngredientDosage Form/ RouteSubmissionCompanySubmission ClassificationSubmission Status
Zocor
NDA #019766
SimvastatinTablet; OralSUPPL-101Msd Merck CoLabelingApproved
Pravachol
NDA #019898
Pravastatin SodiumTablet; OralSUPPL-69Bristol Myers SquibbLabelingApproved
Lipitor
NDA #020702
Atorvastatin CalciumTablet; OralSUPPL-78UpjohnLabelingApproved
Lescol Xl
NDA #021192
Fluvastatin SodiumTablet, Extended Release; OralSUPPL-31NovartisLabelingApproved
Altoprev
NDA #021316
LovastatinTablet, Extended Release; OralSUPPL-36Covis Pharma BvLabelingApproved
Crestor
NDA #021366
Rosuvastatin CalciumTablet; OralSUPPL-42IprLabelingApproved
Vytorin
NDA #021687
Ezetimibe; SimvastatinTablet; OralSUPPL-63Msd IntlLabelingApproved
Livalo
NDA #022363
Pitavastatin CalciumTablet; OralSUPPL-18Kowa CoLabelingApproved
Nucala
BLA #125526
MepolizumabInjectable; Subcutaneous Lyophilized PowerSUPPL-17Glaxosmithkline LlcEfficacyApproved
Liptruzet
NDA #200153
Atorvastatin Calcium; EzetimibeTablet; OralSUPPL-12Merck Sharp DohmeLabelingApproved
Flolipid
NDA #206679
SimvastatinSuspension; OralSUPPL-3Tcg Fluent PharmaLabelingApproved
Zypitamag
NDA #208379
Pitavastatin MagnesiumTablet; OralSUPPL-4MedicureLabelingApproved
Ezallor Sprinkle
NDA #208647
Rosuvastatin CalciumCapsule; OralSUPPL-4Sun Pharma GlobalLabelingApproved
Ezallor Sprinkle
NDA #208647
Rosuvastatin CalciumCapsule; OralSUPPL-4Sun Pharma GlobalLabelingApproved
Nikita
NDA #209875
Pitavastatin SodiumTablet; OralSUPPL-2Lupin LtdLabelingApproved
Nucala
BLA #761122
MepolizumabInjectable; SubcutaneousSUPPL-5GlaxosmithklineLabelingApproved

September 24, 2020

Drug Name and
Application Number
Active IngredientDosage Form/ RouteSubmissionCompanySubmission ClassificationSubmission Status
Arthrotec
NDA #020607
Diclofenac Sodium; MisoprostolTablet, Delayed Release; OralSUPPL-36PfizerLabelingApproved
Arthrotec
NDA #020607
Diclofenac Sodium; MisoprostolTablet, Delayed Release; OralSUPPL-36PfizerLabelingApproved
Arthrotec
NDA #020607
Diclofenac Sodium; MisoprostolTablet, Delayed Release; OralSUPPL-36PfizerLabelingApproved
Implanon
NDA #021529
EtonogestrelImplant; ImplantationSUPPL-19Organon Usa IncLabelingApproved
Implanon
NDA #021529
EtonogestrelImplant; ImplantationSUPPL-20Organon Usa IncLabelingApproved
Implanon
NDA #021529
EtonogestrelImplant; ImplantationSUPPL-19Organon Usa IncLabelingApproved
Nexplanon
NDA #021529
EtonogestrelImplant; ImplantationSUPPL-19Organon Usa IncLabelingApproved
Nexplanon
NDA #021529
EtonogestrelImplant; ImplantationSUPPL-20Organon Usa IncLabelingApproved
Nexplanon
NDA #021529
EtonogestrelImplant; ImplantationSUPPL-19Organon Usa IncLabelingApproved
Reyataz
NDA #021567
Atazanavir SulfateCapsule; OralSUPPL-44Bristol Myers SquibbLabelingApproved
Reyataz
NDA #021567
Atazanavir SulfateCapsule; OralSUPPL-44Bristol Myers SquibbLabelingApproved
Revlimid
NDA #021880
LenalidomideCapsule; OralSUPPL-54CelgeneREMSApproved
Benlysta
BLA #125370
BelimumabInjectable; InjectionSUPPL-71Human Genome Sciences Inc.EfficacyApproved
Stivarga
NDA #203085
RegorafenibTablet; OralSUPPL-12Bayer HlthcareLabelingApproved
Kalydeco
NDA #203188
IvacaftorTablet; OralSUPPL-33Vertex PharmsEfficacyApproved
Reyataz
NDA #206352
Atazanavir SulfatePowder; OralSUPPL-8Bristol Myers SquibbLabelingApproved
Reyataz
NDA #206352
Atazanavir SulfatePowder; OralSUPPL-8Bristol Myers SquibbLabelingApproved
Kalydeco
NDA #207925
IvacaftorGranule; OralSUPPL-11Vertex Pharms IncEfficacyApproved
Alaway
ANDA #208158
Ketotifen FumarateSolution/Drops; OphthalmicORIG-1Bausch Approved
Dimethyl Fumarate
ANDA #210305
Dimethyl FumarateCapsule, Delayed Release; OralORIG-1Cipla Approved
Dimethyl Fumarate
ANDA #210402
Dimethyl FumarateCapsule, Delayed Release; OralORIG-1Amneal Approved
Dimethyl Fumarate
ANDA #210440
Dimethyl FumarateCapsule, Delayed Release; OralORIG-1Alkem Labs Ltd Approved
Dimethyl Fumarate
ANDA #210460
Dimethyl FumarateCapsule, Delayed Release; OralORIG-1Msn Approved
Dimethyl Fumarate
ANDA #210499
Dimethyl FumarateCapsule, Delayed Release; OralORIG-1Accord Hlthcare Approved
Dimethyl Fumarate
ANDA #210500
Dimethyl FumarateCapsule, Delayed Release; OralORIG-1Hetero Labs Ltd Iii Approved
Dimethyl Fumarate
ANDA #210538
Dimethyl FumarateCapsule, Delayed Release; OralORIG-1Zydus Pharms Approved
Naproxen Sodium and Diphenhydramine Hydrochloride
ANDA #213663
Diphenhydramine Hydrochloride; Naproxen SodiumTablet; OralORIG-1Granules India Ltd Approved
Cyanocobalamin
ANDA #214390
CyanocobalaminInjectable; InjectionORIG-1Gland Pharma Ltd Approved

No hay comentarios: